Skyscape Web Viewer : The Maudsley Prescribing Guidelines in Psychiatry : Main Index

View All
Prophylaxis
Propranolol, for tardive dyskinesia
Protein in blood, psychotropic agent effects
Proteinuria, renal impairment assessment
prothrombin time (PT), psychotropic agent effects
proton pump inhibitors (PPIs), safety in older patients/dementia
Prucalopride, for constipation treatment
Pseudobulbar affect, multiple sclerosis
Pseudoparkinsonism (drug-induced parkinsonism) 34 Blood pressure changes with antipsychotics Extrapyramidal symptoms First-generation antipsychotics - place in therapy Negative symptoms Prescribing in human immunodeficiency virus (HIV) Relative adverse effects - a rough guide Valproate
Psychiatric adverse effects of non-psychotropics antiretroviral therapy differential diagnosis drugs and effects Naranjo scale Summary of psychiatric adverse effects of non-psychotropics
Psychodynamic interventions adherence depression psychosis
Psychological/psychosocial interventions anorexia nervosa anxiety spectrum disorders behavioural treatment of insomnia learning difficulties
Psychosis
Psychosis (contâ™d)
Psychosocial and pharmacological interventions in benzodiazepine withdrawal
Psychosocial interventions Anxiety spectrum disorders Benzodiazepine misuse Benzodiazepines, z-drugs and gabapentinoids: dependence, withdrawal effects and discontinuation borderline personality disorder children and adolescents depression insomnia with/without adherence learning disabilities
Psychostimulants attention deficit hyperactivity disorder in adults depression
Psychotherapeutic, post-traumatic stress disorder
Psychotic depression acute treatment combination therapies ECT treatment ketamine maintenance treatment Psychotic depression
Psychotic depression treatment
Psychotic symptoms
Psychotropic drug groups in hepatic impairment
Psychotropic drug risks
Psychotropic drugs driving impairment in overdose interactions with illicit drugs plasma level monitoring smokers steady state target ranges use in renal impairment with alcohol
Psychotropic drugs: choice in patients who continue to drink
Psychotropic drugs in overdose
Psychotropic drug starting doses
Psychotropic medications approved by the UK Medicines and Healthcare products Regulatory Agency (MHRA), European Medicines Agency and the US Food and Drug Administration for children and adolescents (January 2024)
Psychotropics and driving
Psychotropics in epilepsy